"I can confirm that both facilities have been inspected. Momenta supporters must be getting nervous. --from Teva"
Not sure what to read into this. Apparently, they didn't say they had passed. Nor did they say they had failed. But I assume the former. So, would the FDA bother to inspect facilities meant for the manufacture of drug they did not expect to approve in a few months? I doubt it, they don't have the budget or personnel for such frivolity. I think we have to figure tEnoxaparin gets approved by 1H11.